JPC Bulletin

Bedfordshire and Luton Joint Prescribing Committee

Ref: JPC Bulletin 296
Bulletin Date: 23/07/21
Review Date: September 2023

Botulinum Toxin A for treating masseteric hypertrophy and Temporomandibular Joint (TMJ) Disorders in adults aged 18 and over

JPC Recommendations:

To support the East of England Priorities Advisory Committee bulletin and Recommendations.

Formulary status : Red – Specialist use only , no GP prescribing

(click View Bulletin PDF below to access the full bulletin).

Additional Information:

Scroll to Top